Severe fever, inflammation at the inoculation site ... some alarmism, but this alarmism can be heard from any vaccination reaction. According to the doctor's feedback, the incidence of adverse reactions of 23-valent pneumonia vaccine is not high. Compared with other vaccines, the incidence of adverse reactions in pneumonia vaccine is relatively low. The occurrence of vaccination reaction is related to the child's physique. A few people will have transient fever, fatigue and tenderness. . . Generally, no treatment is needed, and it will be fine in a day or two. This is a general reaction to vaccination and is not unique to pneumonia vaccine. I have a realistic example here. In an area where about 20,000 people (mainly imported vaccines) are vaccinated every year, there are about two intractable adverse reactions, such as severe high fever and allergies.
I don't know what kind of American studies you are talking about. It is very irresponsible to say that this vaccine is useless to children and only useful to the elderly. This vaccine is not useless for children, but it is not ideal for children under two years old. As for the specific effects and high-risk groups, you can consult the vaccination doctor, or you can read the vaccine instructions and the informed consent form of pneumonia vaccine vaccination. These are all legally binding. Don't listen to hearsay.
As for American children, they were vaccinated with 7-valent or 13-valent pneumonia conjugate vaccine before they were 2 years old. Therefore, the significance of vaccination with 23-valent vaccine after 2 years old needs to be evaluated. It is very different from our national conditions.
My personal suggestion is vaccination. This vaccine has low adverse reactions and moderate price. It only needs one needle to protect it for five years.
The answer comes from the professional group of disease prevention and control, hoping to help you.